Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pediatrics | 69 | 2023 | 344 | 19.400 |
Why?
|
Neonatal Screening | 35 | 2022 | 59 | 13.000 |
Why?
|
Living Donors | 41 | 2023 | 339 | 11.770 |
Why?
|
Parents | 46 | 2023 | 272 | 11.380 |
Why?
|
Decision Making | 41 | 2023 | 642 | 8.570 |
Why?
|
Kidney Transplantation | 38 | 2021 | 849 | 8.550 |
Why?
|
Genetic Testing | 40 | 2023 | 535 | 7.850 |
Why?
|
Tissue and Organ Procurement | 31 | 2023 | 311 | 7.380 |
Why?
|
Informed Consent | 45 | 2021 | 266 | 6.660 |
Why?
|
Periodicals as Topic | 16 | 2023 | 167 | 6.630 |
Why?
|
Child | 114 | 2023 | 6926 | 6.320 |
Why?
|
Attitude of Health Personnel | 26 | 2023 | 636 | 5.500 |
Why?
|
Organ Transplantation | 13 | 2023 | 265 | 4.740 |
Why?
|
Phenylketonurias | 12 | 2018 | 17 | 4.740 |
Why?
|
Human Experimentation | 17 | 2022 | 39 | 4.570 |
Why?
|
Tissue Donors | 19 | 2023 | 463 | 4.470 |
Why?
|
Personal Autonomy | 25 | 2018 | 112 | 4.160 |
Why?
|
Humans | 304 | 2024 | 86601 | 4.140 |
Why?
|
Bioethics | 10 | 2022 | 35 | 3.830 |
Why?
|
Ethics, Medical | 29 | 2023 | 306 | 3.820 |
Why?
|
Ethics, Research | 13 | 2018 | 52 | 3.630 |
Why?
|
Kidney Failure, Chronic | 11 | 2020 | 509 | 3.610 |
Why?
|
Anemia, Sickle Cell | 10 | 2022 | 131 | 3.560 |
Why?
|
United States | 100 | 2024 | 6665 | 3.540 |
Why?
|
Infant, Newborn | 50 | 2022 | 2378 | 3.530 |
Why?
|
Parental Consent | 22 | 2020 | 35 | 3.520 |
Why?
|
Cystic Fibrosis | 14 | 2011 | 112 | 3.390 |
Why?
|
Physician-Patient Relations | 16 | 2023 | 610 | 3.040 |
Why?
|
Health Policy | 13 | 2021 | 180 | 2.820 |
Why?
|
Truth Disclosure | 8 | 2020 | 87 | 2.720 |
Why?
|
Youth Sports | 4 | 2020 | 7 | 2.690 |
Why?
|
Moral Obligations | 10 | 2020 | 52 | 2.560 |
Why?
|
Pediatricians | 4 | 2020 | 17 | 2.540 |
Why?
|
Adolescent | 53 | 2023 | 8979 | 2.520 |
Why?
|
Biomedical Research | 8 | 2020 | 375 | 2.520 |
Why?
|
History, 20th Century | 19 | 2021 | 312 | 2.440 |
Why?
|
Directive Counseling | 5 | 2020 | 34 | 2.390 |
Why?
|
Authorship | 4 | 2023 | 24 | 2.270 |
Why?
|
Bioethical Issues | 11 | 2020 | 38 | 2.270 |
Why?
|
Confidentiality | 18 | 2015 | 78 | 2.260 |
Why?
|
Treatment Refusal | 8 | 2020 | 60 | 2.180 |
Why?
|
Patient Selection | 13 | 2018 | 685 | 2.170 |
Why?
|
Ethics Committees, Research | 12 | 2023 | 33 | 2.100 |
Why?
|
Genetic Counseling | 13 | 2015 | 100 | 2.090 |
Why?
|
Brain Death | 5 | 2023 | 69 | 2.060 |
Why?
|
Risk Assessment | 31 | 2021 | 2261 | 2.050 |
Why?
|
Sickle Cell Trait | 5 | 2013 | 21 | 2.030 |
Why?
|
Physicians | 14 | 2023 | 673 | 1.960 |
Why?
|
Attitude | 9 | 2019 | 127 | 1.890 |
Why?
|
Genetic Carrier Screening | 10 | 2011 | 60 | 1.880 |
Why?
|
Health Knowledge, Attitudes, Practice | 10 | 2018 | 508 | 1.870 |
Why?
|
Research Subjects | 12 | 2020 | 73 | 1.850 |
Why?
|
Family | 15 | 2023 | 311 | 1.830 |
Why?
|
Altruism | 8 | 2018 | 35 | 1.780 |
Why?
|
Disclosure | 9 | 2016 | 108 | 1.770 |
Why?
|
Publishing | 6 | 2022 | 90 | 1.770 |
Why?
|
Social Justice | 8 | 2022 | 49 | 1.760 |
Why?
|
Female | 88 | 2023 | 44507 | 1.760 |
Why?
|
Incidental Findings | 6 | 2015 | 95 | 1.700 |
Why?
|
Genetic Diseases, Inborn | 7 | 2019 | 101 | 1.690 |
Why?
|
Withholding Treatment | 5 | 2020 | 112 | 1.690 |
Why?
|
Clinical Trials as Topic | 12 | 2021 | 1169 | 1.670 |
Why?
|
Family Relations | 7 | 2021 | 35 | 1.650 |
Why?
|
Minors | 9 | 2020 | 15 | 1.620 |
Why?
|
Siblings | 7 | 2014 | 111 | 1.610 |
Why?
|
Bibliometrics | 5 | 2023 | 36 | 1.590 |
Why?
|
Data Collection | 15 | 2014 | 372 | 1.590 |
Why?
|
Male | 74 | 2020 | 40956 | 1.560 |
Why?
|
Morals | 6 | 2023 | 92 | 1.550 |
Why?
|
Child Welfare | 8 | 2020 | 39 | 1.540 |
Why?
|
Government Regulation | 10 | 2006 | 49 | 1.530 |
Why?
|
Brain Concussion | 4 | 2020 | 59 | 1.510 |
Why?
|
Directed Tissue Donation | 5 | 2017 | 7 | 1.510 |
Why?
|
Child Abuse | 4 | 2020 | 78 | 1.510 |
Why?
|
Child Health | 2 | 2021 | 11 | 1.510 |
Why?
|
Health Behavior | 3 | 2016 | 183 | 1.490 |
Why?
|
Resource Allocation | 5 | 2019 | 65 | 1.490 |
Why?
|
Patient Participation | 9 | 2020 | 216 | 1.470 |
Why?
|
Human Rights | 5 | 2018 | 18 | 1.470 |
Why?
|
Community-Based Participatory Research | 4 | 2010 | 36 | 1.460 |
Why?
|
Attitude to Health | 8 | 2010 | 220 | 1.440 |
Why?
|
Practice Patterns, Physicians' | 4 | 2019 | 581 | 1.390 |
Why?
|
Athletic Injuries | 3 | 2020 | 91 | 1.350 |
Why?
|
Fragile X Syndrome | 5 | 2015 | 15 | 1.340 |
Why?
|
Prenatal Diagnosis | 6 | 2019 | 104 | 1.340 |
Why?
|
Public Health | 4 | 2022 | 129 | 1.340 |
Why?
|
Phenylalanine | 4 | 2018 | 37 | 1.330 |
Why?
|
Vaccination | 5 | 2022 | 254 | 1.310 |
Why?
|
Muscular Dystrophy, Duchenne | 7 | 2015 | 30 | 1.310 |
Why?
|
Ethical Analysis | 7 | 2022 | 23 | 1.310 |
Why?
|
Biological Specimen Banks | 4 | 2012 | 65 | 1.300 |
Why?
|
Policy Making | 10 | 2021 | 62 | 1.290 |
Why?
|
Therapeutic Misconception | 2 | 2021 | 5 | 1.240 |
Why?
|
Physician's Role | 5 | 2018 | 179 | 1.230 |
Why?
|
Patient Advocacy | 5 | 2020 | 49 | 1.200 |
Why?
|
Community-Institutional Relations | 4 | 2010 | 29 | 1.180 |
Why?
|
Vulnerable Populations | 3 | 2020 | 76 | 1.180 |
Why?
|
Mental Competency | 10 | 2016 | 49 | 1.180 |
Why?
|
Socioeconomic Factors | 7 | 2020 | 567 | 1.180 |
Why?
|
Transplant Recipients | 3 | 2022 | 122 | 1.170 |
Why?
|
Vaccination Refusal | 3 | 2022 | 10 | 1.170 |
Why?
|
Waiting Lists | 13 | 2021 | 175 | 1.160 |
Why?
|
Adult | 50 | 2020 | 25640 | 1.160 |
Why?
|
Heterozygote | 5 | 2012 | 365 | 1.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2014 | 878 | 1.140 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2021 | 567 | 1.140 |
Why?
|
Mandatory Programs | 4 | 2021 | 7 | 1.090 |
Why?
|
Research Design | 9 | 2021 | 594 | 1.080 |
Why?
|
Guidelines as Topic | 9 | 2020 | 162 | 1.050 |
Why?
|
Nontherapeutic Human Experimentation | 4 | 2007 | 20 | 1.040 |
Why?
|
Palliative Care | 3 | 2018 | 257 | 1.030 |
Why?
|
Infant | 17 | 2022 | 3045 | 1.030 |
Why?
|
Maple Syrup Urine Disease | 2 | 2018 | 5 | 1.020 |
Why?
|
Parent-Child Relations | 11 | 2012 | 77 | 1.020 |
Why?
|
Child Advocacy | 5 | 2011 | 6 | 1.020 |
Why?
|
United Kingdom | 7 | 2024 | 164 | 1.020 |
Why?
|
Mothers | 7 | 2011 | 141 | 1.010 |
Why?
|
Death | 2 | 2018 | 73 | 1.010 |
Why?
|
Motivation | 5 | 2021 | 287 | 1.000 |
Why?
|
Research Personnel | 5 | 2015 | 67 | 0.990 |
Why?
|
Child, Preschool | 18 | 2021 | 3611 | 0.980 |
Why?
|
Mass Screening | 4 | 2011 | 617 | 0.980 |
Why?
|
Caregivers | 3 | 2019 | 151 | 0.960 |
Why?
|
Mass Media | 2 | 2020 | 26 | 0.960 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2023 | 190 | 0.950 |
Why?
|
Surveys and Questionnaires | 15 | 2023 | 2501 | 0.930 |
Why?
|
Risk | 11 | 2016 | 674 | 0.930 |
Why?
|
Health Facilities | 1 | 2023 | 38 | 0.930 |
Why?
|
Pregnancy | 13 | 2023 | 2893 | 0.930 |
Why?
|
Research | 6 | 2005 | 253 | 0.930 |
Why?
|
Schools | 2 | 2020 | 71 | 0.910 |
Why?
|
Minority Groups | 4 | 2006 | 137 | 0.910 |
Why?
|
Football | 3 | 2020 | 43 | 0.900 |
Why?
|
ABO Blood-Group System | 7 | 2010 | 62 | 0.900 |
Why?
|
Hematologic Tests | 1 | 2022 | 14 | 0.900 |
Why?
|
Heart Arrest | 2 | 2023 | 265 | 0.890 |
Why?
|
Fetal Viability | 1 | 2022 | 9 | 0.890 |
Why?
|
Prisoners | 2 | 2018 | 40 | 0.880 |
Why?
|
Life Support Care | 4 | 2018 | 49 | 0.880 |
Why?
|
Chromosomes | 1 | 2022 | 96 | 0.860 |
Why?
|
Lysosomal Storage Diseases | 2 | 2012 | 8 | 0.850 |
Why?
|
Clinical Decision-Making | 3 | 2020 | 257 | 0.850 |
Why?
|
Registries | 4 | 2023 | 702 | 0.840 |
Why?
|
Physician Executives | 2 | 2013 | 22 | 0.830 |
Why?
|
Healthcare Disparities | 4 | 2020 | 370 | 0.820 |
Why?
|
Public Policy | 7 | 2008 | 52 | 0.820 |
Why?
|
Faculty, Medical | 3 | 2023 | 178 | 0.810 |
Why?
|
Drug Approval | 2 | 2018 | 62 | 0.800 |
Why?
|
Women | 4 | 2008 | 25 | 0.800 |
Why?
|
Ethics, Clinical | 5 | 2010 | 48 | 0.790 |
Why?
|
Mass Vaccination | 1 | 2021 | 8 | 0.790 |
Why?
|
Curriculum | 3 | 2015 | 539 | 0.790 |
Why?
|
Genomics | 4 | 2021 | 720 | 0.790 |
Why?
|
Policy | 2 | 2011 | 34 | 0.790 |
Why?
|
Health Equity | 2 | 2020 | 77 | 0.780 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2020 | 5 | 0.770 |
Why?
|
Graft Survival | 7 | 2021 | 884 | 0.770 |
Why?
|
Practice Guidelines as Topic | 14 | 2020 | 1034 | 0.770 |
Why?
|
Ribonucleotide Reductases | 1 | 2020 | 6 | 0.770 |
Why?
|
Efficiency | 1 | 2020 | 40 | 0.770 |
Why?
|
Internship and Residency | 4 | 2015 | 1004 | 0.770 |
Why?
|
Vaccines | 1 | 2022 | 80 | 0.760 |
Why?
|
Third-Party Consent | 7 | 2009 | 24 | 0.750 |
Why?
|
Pandemics | 3 | 2021 | 740 | 0.750 |
Why?
|
Information Dissemination | 2 | 2019 | 103 | 0.740 |
Why?
|
Ethics | 7 | 2009 | 24 | 0.730 |
Why?
|
Hemoglobin, Sickle | 1 | 2020 | 19 | 0.730 |
Why?
|
Intellectual Disability | 1 | 2021 | 186 | 0.730 |
Why?
|
Kidney | 4 | 2017 | 1241 | 0.720 |
Why?
|
Health Personnel | 3 | 2011 | 202 | 0.720 |
Why?
|
Infant, Premature | 2 | 2022 | 290 | 0.720 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 183 | 0.720 |
Why?
|
Education, Medical, Graduate | 3 | 2015 | 369 | 0.710 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2019 | 24 | 0.710 |
Why?
|
Craniocerebral Trauma | 1 | 2020 | 52 | 0.710 |
Why?
|
Nephrology | 1 | 2020 | 45 | 0.700 |
Why?
|
Racism | 1 | 2021 | 81 | 0.700 |
Why?
|
Sequence Analysis, DNA | 4 | 2019 | 853 | 0.690 |
Why?
|
Societies, Medical | 8 | 2015 | 572 | 0.690 |
Why?
|
Antibiotic Prophylaxis | 1 | 2019 | 71 | 0.690 |
Why?
|
Tissue Banks | 3 | 2008 | 16 | 0.680 |
Why?
|
Phenylketonuria, Maternal | 1 | 2018 | 1 | 0.680 |
Why?
|
Liver Transplantation | 4 | 2018 | 1267 | 0.670 |
Why?
|
Medical History Taking | 1 | 2019 | 80 | 0.670 |
Why?
|
History, 21st Century | 5 | 2021 | 175 | 0.660 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 3 | 2006 | 8 | 0.660 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 238 | 0.650 |
Why?
|
Guideline Adherence | 2 | 2019 | 223 | 0.650 |
Why?
|
Professional-Family Relations | 7 | 2014 | 48 | 0.640 |
Why?
|
Medication Adherence | 1 | 2019 | 129 | 0.640 |
Why?
|
Leukodystrophy, Globoid Cell | 2 | 2015 | 7 | 0.640 |
Why?
|
Interpersonal Relations | 2 | 2018 | 170 | 0.640 |
Why?
|
Editorial Policies | 3 | 2021 | 32 | 0.640 |
Why?
|
Physical Examination | 1 | 2019 | 149 | 0.640 |
Why?
|
Ethics Consultation | 1 | 2018 | 12 | 0.640 |
Why?
|
Risk Factors | 13 | 2021 | 5416 | 0.630 |
Why?
|
Terminal Care | 2 | 2018 | 130 | 0.630 |
Why?
|
Papillomavirus Vaccines | 2 | 2008 | 58 | 0.630 |
Why?
|
Paternalism | 6 | 2003 | 24 | 0.620 |
Why?
|
Cell Cycle Proteins | 1 | 2020 | 388 | 0.620 |
Why?
|
Respiration, Artificial | 1 | 2020 | 334 | 0.620 |
Why?
|
Paternity | 3 | 2011 | 8 | 0.620 |
Why?
|
Refusal to Treat | 3 | 2010 | 27 | 0.620 |
Why?
|
Neuromuscular Diseases | 1 | 2017 | 30 | 0.610 |
Why?
|
Genetic Research | 3 | 2008 | 17 | 0.610 |
Why?
|
Health Status | 3 | 2015 | 360 | 0.610 |
Why?
|
Choice Behavior | 1 | 2018 | 160 | 0.610 |
Why?
|
Urban Population | 1 | 2018 | 213 | 0.600 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 153 | 0.600 |
Why?
|
Transplantation | 3 | 2010 | 39 | 0.600 |
Why?
|
Sexism | 1 | 2017 | 51 | 0.600 |
Why?
|
Physicians, Women | 1 | 2017 | 53 | 0.590 |
Why?
|
Ethical Theory | 2 | 2016 | 10 | 0.590 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 1373 | 0.580 |
Why?
|
Age Factors | 10 | 2021 | 1849 | 0.570 |
Why?
|
Health Services Accessibility | 5 | 2019 | 394 | 0.560 |
Why?
|
Middle Aged | 23 | 2019 | 25017 | 0.560 |
Why?
|
Donor Selection | 3 | 2017 | 67 | 0.540 |
Why?
|
Health Care Rationing | 2 | 2010 | 83 | 0.540 |
Why?
|
Educational Status | 2 | 2013 | 188 | 0.530 |
Why?
|
Neoplasms | 4 | 2021 | 2897 | 0.530 |
Why?
|
Medical Errors | 2 | 2015 | 115 | 0.530 |
Why?
|
Duty to Recontact | 1 | 2015 | 1 | 0.520 |
Why?
|
Clinical Competence | 2 | 2012 | 751 | 0.520 |
Why?
|
Beneficence | 7 | 2018 | 33 | 0.520 |
Why?
|
Coercion | 2 | 2012 | 15 | 0.510 |
Why?
|
Therapeutic Human Experimentation | 4 | 2006 | 20 | 0.510 |
Why?
|
Cardiac Surgical Procedures | 1 | 2019 | 462 | 0.510 |
Why?
|
Illinois | 5 | 2019 | 462 | 0.500 |
Why?
|
Dissent and Disputes | 4 | 2023 | 28 | 0.490 |
Why?
|
Professional Competence | 2 | 2013 | 68 | 0.490 |
Why?
|
Pilot Projects | 8 | 2013 | 839 | 0.490 |
Why?
|
Social Values | 4 | 2007 | 44 | 0.490 |
Why?
|
Child Abuse, Sexual | 1 | 2014 | 19 | 0.490 |
Why?
|
Infant, Newborn, Diseases | 1 | 2015 | 111 | 0.480 |
Why?
|
Psychology, Adolescent | 1 | 2014 | 29 | 0.480 |
Why?
|
Histocompatibility | 2 | 2006 | 71 | 0.480 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2015 | 105 | 0.480 |
Why?
|
Tissue and Organ Harvesting | 1 | 2014 | 78 | 0.470 |
Why?
|
Delivery of Health Care | 3 | 2023 | 426 | 0.470 |
Why?
|
Communication | 7 | 2020 | 440 | 0.470 |
Why?
|
Herpes Simplex | 1 | 2015 | 202 | 0.460 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 102 | 0.460 |
Why?
|
Sex Factors | 4 | 2020 | 1054 | 0.460 |
Why?
|
Residence Characteristics | 2 | 2012 | 197 | 0.460 |
Why?
|
Health Physics | 1 | 2013 | 18 | 0.450 |
Why?
|
Codes of Ethics | 3 | 2008 | 12 | 0.450 |
Why?
|
Cadaver | 4 | 2012 | 185 | 0.450 |
Why?
|
Infant Mortality | 1 | 2013 | 59 | 0.450 |
Why?
|
Freedom | 7 | 1999 | 18 | 0.440 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2013 | 64 | 0.430 |
Why?
|
Tyrosine | 1 | 2012 | 133 | 0.430 |
Why?
|
Awareness | 1 | 2013 | 93 | 0.430 |
Why?
|
Prejudice | 2 | 2010 | 49 | 0.420 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 58 | 0.420 |
Why?
|
Public Opinion | 3 | 2021 | 43 | 0.420 |
Why?
|
Community Participation | 1 | 2012 | 36 | 0.420 |
Why?
|
Focus Groups | 5 | 2012 | 155 | 0.420 |
Why?
|
Chicago | 7 | 2018 | 1379 | 0.420 |
Why?
|
Postpartum Period | 1 | 2013 | 135 | 0.420 |
Why?
|
Social Determinants of Health | 2 | 2023 | 78 | 0.420 |
Why?
|
Cause of Death | 1 | 2013 | 277 | 0.410 |
Why?
|
Shame | 1 | 2011 | 4 | 0.410 |
Why?
|
Health Surveys | 3 | 2013 | 239 | 0.410 |
Why?
|
Surgery, Plastic | 1 | 2012 | 42 | 0.410 |
Why?
|
Asthma | 3 | 2005 | 955 | 0.410 |
Why?
|
Comprehension | 2 | 2011 | 79 | 0.400 |
Why?
|
Athletes | 1 | 2011 | 46 | 0.400 |
Why?
|
Self Disclosure | 1 | 2011 | 31 | 0.400 |
Why?
|
Surgeons | 1 | 2015 | 238 | 0.400 |
Why?
|
Sweat | 1 | 2011 | 4 | 0.400 |
Why?
|
Renal Dialysis | 4 | 2021 | 355 | 0.390 |
Why?
|
Mandatory Testing | 1 | 2010 | 3 | 0.390 |
Why?
|
Sports | 1 | 2011 | 39 | 0.390 |
Why?
|
Depression, Postpartum | 1 | 2011 | 14 | 0.390 |
Why?
|
Sports Medicine | 1 | 2011 | 56 | 0.390 |
Why?
|
Mother-Child Relations | 1 | 2010 | 26 | 0.390 |
Why?
|
Hospital Mortality | 1 | 2013 | 348 | 0.380 |
Why?
|
Placebos | 3 | 2005 | 218 | 0.370 |
Why?
|
Resuscitation Orders | 2 | 2003 | 62 | 0.370 |
Why?
|
Immunization Programs | 3 | 2008 | 23 | 0.370 |
Why?
|
Medical Oncology | 2 | 2021 | 359 | 0.370 |
Why?
|
Methylmalonic Acid | 1 | 2010 | 6 | 0.370 |
Why?
|
Students | 1 | 2011 | 147 | 0.370 |
Why?
|
Medicine in Literature | 1 | 2010 | 8 | 0.370 |
Why?
|
Philosophy, Medical | 1 | 2010 | 17 | 0.370 |
Why?
|
Metabolism, Inborn Errors | 1 | 2010 | 30 | 0.370 |
Why?
|
Histocompatibility Testing | 5 | 2011 | 154 | 0.370 |
Why?
|
Counseling | 3 | 2009 | 145 | 0.360 |
Why?
|
Risk Management | 1 | 2010 | 43 | 0.360 |
Why?
|
Young Adult | 9 | 2019 | 5974 | 0.360 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 157 | 0.360 |
Why?
|
Quality of Health Care | 3 | 2019 | 380 | 0.360 |
Why?
|
Neonatology | 2 | 2007 | 11 | 0.360 |
Why?
|
National Health Programs | 1 | 2009 | 20 | 0.350 |
Why?
|
Malpractice | 2 | 2002 | 57 | 0.350 |
Why?
|
Social Responsibility | 5 | 2007 | 57 | 0.350 |
Why?
|
Health Care Surveys | 4 | 2019 | 278 | 0.340 |
Why?
|
Dyskeratosis Congenita | 1 | 2008 | 1 | 0.340 |
Why?
|
Prenatal Care | 2 | 2013 | 72 | 0.340 |
Why?
|
Fee-for-Service Plans | 1 | 2009 | 30 | 0.340 |
Why?
|
Nuclear Family | 1 | 2009 | 92 | 0.340 |
Why?
|
Universities | 1 | 2009 | 135 | 0.340 |
Why?
|
Patient Education as Topic | 3 | 2012 | 351 | 0.340 |
Why?
|
Anemia, Aplastic | 1 | 2008 | 30 | 0.340 |
Why?
|
Public Health Administration | 1 | 2008 | 16 | 0.330 |
Why?
|
Elective Surgical Procedures | 1 | 2010 | 116 | 0.330 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2009 | 72 | 0.330 |
Why?
|
Drug Prescriptions | 1 | 2010 | 141 | 0.330 |
Why?
|
Self Care | 1 | 2010 | 164 | 0.330 |
Why?
|
Resuscitation | 1 | 2009 | 100 | 0.330 |
Why?
|
Research Support as Topic | 3 | 2010 | 80 | 0.330 |
Why?
|
Personhood | 2 | 2006 | 17 | 0.320 |
Why?
|
Communicable Diseases | 1 | 2008 | 63 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 5 | 2013 | 2270 | 0.310 |
Why?
|
Genetic Privacy | 3 | 2004 | 12 | 0.310 |
Why?
|
Fetal Blood | 1 | 2008 | 90 | 0.310 |
Why?
|
Soccer | 2 | 2017 | 17 | 0.300 |
Why?
|
Growth | 1 | 2007 | 43 | 0.300 |
Why?
|
Ethical Review | 2 | 2004 | 8 | 0.300 |
Why?
|
Tandem Mass Spectrometry | 3 | 2012 | 103 | 0.300 |
Why?
|
Conscience | 1 | 2007 | 20 | 0.300 |
Why?
|
Value of Life | 1 | 2007 | 22 | 0.300 |
Why?
|
Disabled Children | 1 | 2007 | 43 | 0.290 |
Why?
|
Self Report | 2 | 2019 | 288 | 0.290 |
Why?
|
Publications | 2 | 2023 | 26 | 0.290 |
Why?
|
Risk-Taking | 2 | 2005 | 148 | 0.280 |
Why?
|
Federal Government | 3 | 2006 | 29 | 0.280 |
Why?
|
Patient Access to Records | 1 | 2006 | 2 | 0.280 |
Why?
|
Pregnancy Outcome | 1 | 2008 | 247 | 0.280 |
Why?
|
Violence | 3 | 2004 | 143 | 0.280 |
Why?
|
Persistent Vegetative State | 1 | 2006 | 9 | 0.280 |
Why?
|
Blood Group Incompatibility | 3 | 2006 | 18 | 0.280 |
Why?
|
Sex Offenses | 1 | 2006 | 13 | 0.280 |
Why?
|
Sexuality | 2 | 1996 | 40 | 0.280 |
Why?
|
Adolescent Health Services | 1 | 2006 | 11 | 0.280 |
Why?
|
School Health Services | 1 | 2006 | 16 | 0.280 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2018 | 122 | 0.270 |
Why?
|
Apolipoproteins E | 1 | 2006 | 129 | 0.270 |
Why?
|
Congresses as Topic | 2 | 2017 | 116 | 0.270 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2008 | 275 | 0.270 |
Why?
|
Congenital Abnormalities | 2 | 2003 | 63 | 0.270 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 239 | 0.270 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2006 | 155 | 0.270 |
Why?
|
Models, Theoretical | 3 | 2010 | 482 | 0.260 |
Why?
|
Australia | 2 | 2021 | 99 | 0.260 |
Why?
|
Contraception | 2 | 1996 | 88 | 0.260 |
Why?
|
Algorithms | 3 | 2015 | 1830 | 0.260 |
Why?
|
Genetics, Behavioral | 1 | 2004 | 22 | 0.260 |
Why?
|
Anti-Asthmatic Agents | 1 | 2005 | 76 | 0.260 |
Why?
|
Bone Marrow Transplantation | 1 | 2006 | 286 | 0.260 |
Why?
|
Legal Guardians | 2 | 2006 | 7 | 0.260 |
Why?
|
Glucose Clamp Technique | 1 | 2004 | 39 | 0.250 |
Why?
|
Parenting | 2 | 2020 | 67 | 0.250 |
Why?
|
Aged | 10 | 2018 | 18402 | 0.240 |
Why?
|
Family Health | 2 | 2004 | 162 | 0.240 |
Why?
|
Prognosis | 6 | 2018 | 3674 | 0.230 |
Why?
|
Emotions | 2 | 2019 | 341 | 0.230 |
Why?
|
State Government | 2 | 2020 | 20 | 0.230 |
Why?
|
Safety | 2 | 2020 | 152 | 0.230 |
Why?
|
Adolescent Development | 1 | 2003 | 18 | 0.230 |
Why?
|
Civil Rights | 3 | 1997 | 7 | 0.220 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 1621 | 0.220 |
Why?
|
Organ Preservation | 1 | 2023 | 83 | 0.220 |
Why?
|
Organizational Policy | 2 | 2003 | 55 | 0.220 |
Why?
|
Public Housing | 1 | 2002 | 7 | 0.210 |
Why?
|
Obstetrics | 1 | 2004 | 120 | 0.210 |
Why?
|
Lead Poisoning | 1 | 2002 | 10 | 0.210 |
Why?
|
Prevalence | 2 | 2021 | 1239 | 0.210 |
Why?
|
Consensus | 1 | 2023 | 335 | 0.210 |
Why?
|
Canada | 3 | 2009 | 204 | 0.200 |
Why?
|
Religion and Medicine | 2 | 2007 | 122 | 0.200 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 144 | 0.200 |
Why?
|
Hemoglobinopathies | 2 | 2011 | 10 | 0.200 |
Why?
|
Vaccination Coverage | 1 | 2021 | 5 | 0.200 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 108 | 0.200 |
Why?
|
Advisory Committees | 2 | 2018 | 90 | 0.200 |
Why?
|
Neurologists | 1 | 2021 | 6 | 0.200 |
Why?
|
Interviews as Topic | 2 | 2015 | 319 | 0.200 |
Why?
|
Pancreas Transplantation | 1 | 2021 | 103 | 0.200 |
Why?
|
Culture | 3 | 2009 | 53 | 0.190 |
Why?
|
AIDS Serodiagnosis | 1 | 2001 | 25 | 0.190 |
Why?
|
Informed Consent By Minors | 1 | 2020 | 2 | 0.190 |
Why?
|
Patient Self-Determination Act | 1 | 2020 | 4 | 0.190 |
Why?
|
Prospective Studies | 4 | 2021 | 4210 | 0.190 |
Why?
|
Principle-Based Ethics | 1 | 2020 | 4 | 0.190 |
Why?
|
Pancreatic Diseases | 1 | 2001 | 52 | 0.190 |
Why?
|
Transplants | 1 | 2001 | 40 | 0.190 |
Why?
|
Interinstitutional Relations | 1 | 2000 | 28 | 0.190 |
Why?
|
Thymidine Kinase | 1 | 2020 | 30 | 0.190 |
Why?
|
Chronic Disease | 2 | 2018 | 970 | 0.190 |
Why?
|
Crowdsourcing | 1 | 2020 | 12 | 0.190 |
Why?
|
New York City | 1 | 2020 | 59 | 0.190 |
Why?
|
Morbidity | 1 | 2021 | 148 | 0.190 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 364 | 0.190 |
Why?
|
Creativity | 1 | 2020 | 10 | 0.190 |
Why?
|
Intersectoral Collaboration | 1 | 2020 | 10 | 0.190 |
Why?
|
Conflict of Interest | 3 | 2010 | 67 | 0.190 |
Why?
|
Genetics, Medical | 4 | 2014 | 52 | 0.190 |
Why?
|
Twins, Monozygotic | 1 | 2020 | 57 | 0.190 |
Why?
|
Medical Futility | 1 | 2020 | 28 | 0.190 |
Why?
|
Patient Care | 3 | 1999 | 100 | 0.190 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 216 | 0.190 |
Why?
|
Goals | 3 | 1996 | 67 | 0.190 |
Why?
|
Access to Information | 2 | 2015 | 27 | 0.180 |
Why?
|
Proxy | 1 | 2020 | 24 | 0.180 |
Why?
|
Rheumatic Fever | 1 | 2019 | 12 | 0.180 |
Why?
|
Penicillins | 1 | 2019 | 20 | 0.180 |
Why?
|
Drug Industry | 1 | 2000 | 54 | 0.180 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 297 | 0.180 |
Why?
|
Men | 2 | 1996 | 10 | 0.180 |
Why?
|
Democracy | 2 | 1996 | 4 | 0.180 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2006 | 763 | 0.180 |
Why?
|
Global Health | 1 | 2021 | 193 | 0.180 |
Why?
|
Tay-Sachs Disease | 2 | 2011 | 6 | 0.180 |
Why?
|
Education, Medical | 1 | 2022 | 233 | 0.180 |
Why?
|
Patient Transfer | 1 | 2020 | 91 | 0.180 |
Why?
|
Deception | 2 | 1996 | 20 | 0.170 |
Why?
|
Environmental Exposure | 1 | 2002 | 296 | 0.170 |
Why?
|
Netherlands | 1 | 2019 | 19 | 0.170 |
Why?
|
Dialysis | 1 | 2019 | 24 | 0.170 |
Why?
|
Genome, Human | 2 | 2015 | 756 | 0.170 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 806 | 0.170 |
Why?
|
Jews | 2 | 2011 | 42 | 0.170 |
Why?
|
Thanatology | 1 | 2018 | 1 | 0.170 |
Why?
|
DNA, Recombinant | 1 | 2018 | 67 | 0.170 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 12 | 0.170 |
Why?
|
Attitude to Death | 1 | 2018 | 36 | 0.170 |
Why?
|
Privacy | 3 | 2010 | 20 | 0.160 |
Why?
|
Volition | 1 | 2018 | 15 | 0.160 |
Why?
|
Hymen | 1 | 1998 | 1 | 0.160 |
Why?
|
Delayed Graft Function | 1 | 2018 | 12 | 0.160 |
Why?
|
Health Status Disparities | 1 | 2020 | 170 | 0.160 |
Why?
|
HLA Antigens | 2 | 2010 | 232 | 0.160 |
Why?
|
Ectromelia | 1 | 2018 | 4 | 0.160 |
Why?
|
Ethylene Glycols | 1 | 2018 | 10 | 0.160 |
Why?
|
Genetic Therapy | 2 | 2018 | 342 | 0.160 |
Why?
|
Program Evaluation | 2 | 2009 | 297 | 0.160 |
Why?
|
Thalidomide | 1 | 2018 | 54 | 0.160 |
Why?
|
Academic Medical Centers | 1 | 2000 | 379 | 0.160 |
Why?
|
Advance Directive Adherence | 1 | 1997 | 6 | 0.160 |
Why?
|
Genetic Services | 1 | 1997 | 7 | 0.160 |
Why?
|
Patient Preference | 2 | 2016 | 105 | 0.150 |
Why?
|
Mutation | 2 | 2023 | 3967 | 0.150 |
Why?
|
Christianity | 1 | 1997 | 36 | 0.150 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 996 | 0.150 |
Why?
|
Circumcision, Male | 1 | 1997 | 18 | 0.150 |
Why?
|
Psychology, Child | 2 | 2014 | 12 | 0.150 |
Why?
|
United States Food and Drug Administration | 1 | 2018 | 127 | 0.150 |
Why?
|
Hockey | 1 | 2017 | 9 | 0.150 |
Why?
|
Trust | 2 | 2012 | 95 | 0.150 |
Why?
|
Iatrogenic Disease | 1 | 1997 | 69 | 0.150 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 857 | 0.150 |
Why?
|
Gene-Environment Interaction | 1 | 2018 | 103 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
Apolipoprotein L1 | 1 | 2016 | 7 | 0.140 |
Why?
|
Predictive Value of Tests | 3 | 2008 | 1673 | 0.140 |
Why?
|
Social Control, Formal | 1 | 1996 | 12 | 0.140 |
Why?
|
Diseases in Twins | 1 | 2016 | 65 | 0.140 |
Why?
|
Longitudinal Studies | 2 | 2011 | 1019 | 0.140 |
Why?
|
Quality of Life | 3 | 2021 | 1583 | 0.140 |
Why?
|
Multivariate Analysis | 2 | 2015 | 999 | 0.140 |
Why?
|
Nephrectomy | 2 | 2008 | 294 | 0.140 |
Why?
|
International Cooperation | 1 | 2016 | 127 | 0.140 |
Why?
|
Follow-Up Studies | 2 | 2020 | 3636 | 0.140 |
Why?
|
Patient Harm | 1 | 2015 | 7 | 0.130 |
Why?
|
Consent Forms | 2 | 2006 | 11 | 0.130 |
Why?
|
Medicare | 1 | 2019 | 406 | 0.130 |
Why?
|
Unsafe Sex | 1 | 2015 | 42 | 0.130 |
Why?
|
Fathers | 1 | 1996 | 70 | 0.130 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 1990 | 0.130 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2015 | 17 | 0.130 |
Why?
|
Chickenpox | 1 | 1995 | 39 | 0.130 |
Why?
|
Peer Review, Research | 2 | 2010 | 36 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2015 | 34 | 0.130 |
Why?
|
Herpesvirus 3, Human | 1 | 1995 | 43 | 0.130 |
Why?
|
Viral Vaccines | 1 | 1995 | 43 | 0.130 |
Why?
|
Sexual Abstinence | 2 | 2008 | 10 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2015 | 860 | 0.120 |
Why?
|
Epidemiologic Factors | 2 | 2005 | 5 | 0.120 |
Why?
|
Mental Health | 1 | 2015 | 162 | 0.120 |
Why?
|
Heart Transplantation | 1 | 2019 | 705 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2015 | 160 | 0.120 |
Why?
|
Immunization Schedule | 1 | 2013 | 21 | 0.120 |
Why?
|
Quadriplegia | 1 | 1993 | 22 | 0.120 |
Why?
|
Qualitative Research | 1 | 2015 | 256 | 0.120 |
Why?
|
Diet | 1 | 2016 | 443 | 0.110 |
Why?
|
Religion | 2 | 2008 | 87 | 0.110 |
Why?
|
Models, Psychological | 1 | 2014 | 157 | 0.110 |
Why?
|
Glycogen Storage Disease Type II | 1 | 2012 | 3 | 0.110 |
Why?
|
New York | 1 | 2012 | 69 | 0.110 |
Why?
|
Severity of Illness Index | 1 | 2018 | 1801 | 0.110 |
Why?
|
Age of Onset | 2 | 2003 | 310 | 0.110 |
Why?
|
Graft Rejection | 1 | 2018 | 1065 | 0.100 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 351 | 0.100 |
Why?
|
Benchmarking | 1 | 2012 | 78 | 0.100 |
Why?
|
Treatment Outcome | 4 | 2021 | 7988 | 0.100 |
Why?
|
Logistic Models | 1 | 2015 | 1185 | 0.100 |
Why?
|
Brain | 1 | 2022 | 2216 | 0.100 |
Why?
|
Substance-Related Disorders | 1 | 2015 | 394 | 0.100 |
Why?
|
Genotype | 1 | 2016 | 1850 | 0.100 |
Why?
|
Brazil | 1 | 2011 | 69 | 0.100 |
Why?
|
Carrier State | 1 | 2010 | 39 | 0.090 |
Why?
|
Health Education | 1 | 2011 | 100 | 0.090 |
Why?
|
United States Office of Research Integrity | 2 | 2013 | 2 | 0.090 |
Why?
|
Negotiating | 1 | 2010 | 19 | 0.090 |
Why?
|
Chimera | 1 | 2010 | 56 | 0.090 |
Why?
|
Training Support | 1 | 2009 | 23 | 0.090 |
Why?
|
Gynecology | 1 | 2011 | 124 | 0.090 |
Why?
|
Mosaicism | 1 | 2010 | 67 | 0.090 |
Why?
|
Retrospective Studies | 1 | 2023 | 8475 | 0.090 |
Why?
|
Accreditation | 1 | 2009 | 60 | 0.090 |
Why?
|
Hospitals, University | 2 | 2002 | 194 | 0.090 |
Why?
|
Demography | 1 | 2009 | 177 | 0.090 |
Why?
|
Regression Analysis | 1 | 2010 | 596 | 0.090 |
Why?
|
Reimbursement, Incentive | 1 | 2009 | 37 | 0.090 |
Why?
|
Professional-Patient Relations | 2 | 2002 | 53 | 0.090 |
Why?
|
Poverty | 1 | 2010 | 173 | 0.080 |
Why?
|
Papanicolaou Test | 1 | 2008 | 38 | 0.080 |
Why?
|
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2008 | 5 | 0.080 |
Why?
|
Evaluation Studies as Topic | 1 | 2009 | 274 | 0.080 |
Why?
|
Vaginal Smears | 1 | 2008 | 68 | 0.080 |
Why?
|
ROC Curve | 1 | 2011 | 752 | 0.080 |
Why?
|
Program Development | 1 | 2009 | 124 | 0.080 |
Why?
|
Quality Assurance, Health Care | 2 | 2002 | 220 | 0.080 |
Why?
|
Cultural Diversity | 2 | 2021 | 51 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2010 | 217 | 0.080 |
Why?
|
Family Practice | 1 | 2008 | 84 | 0.080 |
Why?
|
Incidence | 1 | 2013 | 1576 | 0.080 |
Why?
|
Population Surveillance | 1 | 2009 | 219 | 0.080 |
Why?
|
Telomere | 1 | 2008 | 108 | 0.080 |
Why?
|
Time Factors | 3 | 2015 | 5209 | 0.080 |
Why?
|
Postoperative Complications | 1 | 2018 | 2207 | 0.080 |
Why?
|
Ethics Committees | 2 | 2008 | 8 | 0.080 |
Why?
|
Obesity | 2 | 2004 | 963 | 0.080 |
Why?
|
Health Care Costs | 1 | 2009 | 237 | 0.070 |
Why?
|
Euthanasia | 1 | 2007 | 16 | 0.070 |
Why?
|
Growth Hormone | 1 | 2007 | 97 | 0.070 |
Why?
|
Hemophilia A | 1 | 2006 | 8 | 0.070 |
Why?
|
Uncertainty | 1 | 2007 | 71 | 0.070 |
Why?
|
Wisconsin | 1 | 2006 | 39 | 0.070 |
Why?
|
Colorado | 1 | 2006 | 35 | 0.070 |
Why?
|
Alleles | 1 | 2010 | 1127 | 0.070 |
Why?
|
Medicaid | 1 | 2009 | 217 | 0.070 |
Why?
|
Florida | 1 | 2006 | 54 | 0.070 |
Why?
|
Student Health Services | 1 | 2006 | 1 | 0.070 |
Why?
|
Quebec | 1 | 2006 | 11 | 0.070 |
Why?
|
Adult Children | 1 | 2006 | 12 | 0.070 |
Why?
|
Group Processes | 2 | 1997 | 31 | 0.070 |
Why?
|
Disabled Persons | 1 | 2007 | 67 | 0.070 |
Why?
|
Fertility | 1 | 2006 | 115 | 0.070 |
Why?
|
Medically Uninsured | 1 | 2005 | 58 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 526 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2005 | 153 | 0.070 |
Why?
|
Reference Standards | 1 | 2005 | 159 | 0.060 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2004 | 14 | 0.060 |
Why?
|
Insurance, Health | 1 | 2005 | 160 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2013 | 2887 | 0.060 |
Why?
|
Mass Spectrometry | 1 | 2004 | 188 | 0.060 |
Why?
|
Patient Dropouts | 1 | 2004 | 28 | 0.060 |
Why?
|
Reproduction | 1 | 2005 | 195 | 0.060 |
Why?
|
Psychology | 1 | 2003 | 24 | 0.060 |
Why?
|
Patient Care Team | 1 | 2006 | 280 | 0.060 |
Why?
|
Social Environment | 1 | 2004 | 188 | 0.060 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2003 | 5 | 0.060 |
Why?
|
Sample Size | 1 | 2003 | 130 | 0.060 |
Why?
|
Voluntary Programs | 1 | 2002 | 1 | 0.060 |
Why?
|
Child, Hospitalized | 1 | 2003 | 33 | 0.060 |
Why?
|
Recurrence | 1 | 2006 | 1139 | 0.060 |
Why?
|
Contraception Behavior | 1 | 2003 | 26 | 0.050 |
Why?
|
Hearing Tests | 1 | 2022 | 10 | 0.050 |
Why?
|
Reading | 1 | 2022 | 30 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2006 | 470 | 0.050 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2003 | 99 | 0.050 |
Why?
|
Operating Rooms | 1 | 2003 | 126 | 0.050 |
Why?
|
Cytomegalovirus | 1 | 2022 | 76 | 0.050 |
Why?
|
Anecdotes as Topic | 1 | 2002 | 15 | 0.050 |
Why?
|
Adoption | 1 | 2001 | 9 | 0.050 |
Why?
|
Baltimore | 1 | 2002 | 36 | 0.050 |
Why?
|
Maryland | 1 | 2002 | 35 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2002 | 24 | 0.050 |
Why?
|
Consciousness | 1 | 2022 | 26 | 0.050 |
Why?
|
Adolescent Behavior | 1 | 2003 | 106 | 0.050 |
Why?
|
Social Discrimination | 1 | 2021 | 5 | 0.050 |
Why?
|
Social Class | 1 | 2002 | 127 | 0.050 |
Why?
|
Immunogenicity, Vaccine | 1 | 2021 | 13 | 0.050 |
Why?
|
Stereotyping | 1 | 2001 | 13 | 0.050 |
Why?
|
Brain Stem | 1 | 2022 | 165 | 0.050 |
Why?
|
Information Services | 1 | 2001 | 23 | 0.050 |
Why?
|
Cost of Illness | 1 | 2002 | 150 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2015 | 6501 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2002 | 115 | 0.050 |
Why?
|
Decision Trees | 1 | 2000 | 63 | 0.050 |
Why?
|
Probability | 1 | 2001 | 355 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2007 | 2705 | 0.050 |
Why?
|
Sexual Behavior | 1 | 2003 | 302 | 0.050 |
Why?
|
Patient Acuity | 1 | 2019 | 32 | 0.050 |
Why?
|
Animals | 1 | 2019 | 26581 | 0.040 |
Why?
|
Patients | 1 | 2000 | 100 | 0.040 |
Why?
|
Patient-Centered Care | 1 | 2002 | 202 | 0.040 |
Why?
|
Advance Care Planning | 1 | 2000 | 43 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2000 | 192 | 0.040 |
Why?
|
Societies | 1 | 1999 | 12 | 0.040 |
Why?
|
Containment of Biohazards | 1 | 2018 | 8 | 0.040 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 231 | 0.040 |
Why?
|
Learning | 1 | 2021 | 280 | 0.040 |
Why?
|
Patient Safety | 1 | 2021 | 212 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2002 | 454 | 0.040 |
Why?
|
Academies and Institutes | 2 | 2008 | 31 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2018 | 123 | 0.040 |
Why?
|
Behavioral Research | 1 | 1997 | 10 | 0.040 |
Why?
|
Refusal to Participate | 1 | 1997 | 2 | 0.040 |
Why?
|
Intention | 1 | 1997 | 51 | 0.040 |
Why?
|
Primary Health Care | 1 | 2000 | 339 | 0.040 |
Why?
|
Rape | 1 | 1996 | 17 | 0.040 |
Why?
|
Jurisprudence | 1 | 1996 | 25 | 0.040 |
Why?
|
Education | 1 | 1996 | 58 | 0.040 |
Why?
|
Parental Notification | 1 | 1996 | 7 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2018 | 384 | 0.040 |
Why?
|
Social Change | 1 | 1996 | 7 | 0.040 |
Why?
|
Feasibility Studies | 1 | 1998 | 751 | 0.040 |
Why?
|
Pregnant Women | 1 | 1996 | 35 | 0.030 |
Why?
|
Sexually Transmitted Diseases | 1 | 1997 | 91 | 0.030 |
Why?
|
Survival Analysis | 1 | 2019 | 1538 | 0.030 |
Why?
|
Italy | 1 | 2015 | 106 | 0.030 |
Why?
|
Life Expectancy | 1 | 2015 | 86 | 0.030 |
Why?
|
Geography | 1 | 2015 | 223 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 1995 | 140 | 0.030 |
Why?
|
Politics | 1 | 1994 | 50 | 0.030 |
Why?
|
Survival Rate | 1 | 2018 | 1860 | 0.030 |
Why?
|
Penetrance | 1 | 2013 | 44 | 0.030 |
Why?
|
Patient Rights | 1 | 2013 | 16 | 0.030 |
Why?
|
Pulmonary Surfactants | 1 | 2013 | 19 | 0.030 |
Why?
|
Individuality | 1 | 1994 | 109 | 0.030 |
Why?
|
Human Body | 1 | 1993 | 6 | 0.030 |
Why?
|
Spinal Cord Injuries | 1 | 1993 | 54 | 0.030 |
Why?
|
Exome | 1 | 2013 | 127 | 0.030 |
Why?
|
Bone Marrow | 1 | 1994 | 435 | 0.030 |
Why?
|
HIV Infections | 1 | 2001 | 772 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 456 | 0.030 |
Why?
|
Cognition | 1 | 1995 | 570 | 0.020 |
Why?
|
Fees and Charges | 1 | 2009 | 14 | 0.020 |
Why?
|
Computer Simulation | 1 | 2013 | 1078 | 0.020 |
Why?
|
Oxygen | 1 | 2013 | 726 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 451 | 0.020 |
Why?
|
Pedigree | 1 | 2004 | 966 | 0.010 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2001 | 44 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2001 | 106 | 0.010 |
Why?
|